‘Body-on-a-chip’ device screens human heart cells for drug toxicity


'body-on-a-chip'Researchers at Kyoto University‘s Institute for Integrated Cell-Material Sciences have developed a ‘body-on-a-chip’ device that can evaluate the side-effects of drugs on human cells, according to a study published today in the Royal Society of Chemistry Advances.

The device was used to test the toxicity of doxorubicin, a cancer-killing drug, on human heart cells. The researchers found that although the drug wasn’t toxic to the cells, a metabolite of the drug was.

Get the full story at our sister site, Drug Delivery Business News.


Want to stay on top of MDO content? Subscribe to our e-newsletter.

Speak Your Mind